NCT05176223 2026-02-05
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
Mayo Clinic
Phase 2 Completed
Clinical Trials
11 trialsNCT04762888 2025-10-31
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer
Mayo Clinic
Phase 2 Completed
NCT06521775 2025-09-12
An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma
Mayo Clinic
Phase 2 Completed
NCT05547386 2025-07-18
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 3 Completed
NCT04750473 2025-01-17
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Emory University
Phase 1 Completed
NCT04310540 2024-09-19
PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT04216134 2023-06-15
68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer
City of Hope Medical Center
Phase 1 Completed
NCT03368547 2023-04-12
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
Jonsson Comprehensive Cancer Center
Phase NA Completed
NCT04050215 2021-09-30
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT02940262 2021-07-02
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
Jonsson Comprehensive Cancer Center
Phase 3 Completed
NCT04282824 2020-12-02
MSG PSMA PET
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed